Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;131(1):83-92.
doi: 10.1111/bcpt.13741. Epub 2022 May 17.

Short-term mortality following tramadol poisonings in Denmark

Affiliations

Short-term mortality following tramadol poisonings in Denmark

Anne Mette Skov Sørensen et al. Basic Clin Pharmacol Toxicol. 2022 Jul.

Abstract

Tramadol is a commonly used opioid with a potential of addiction and abuse. Using Danish nationwide registers, we aimed to (1) characterise opioid poisonings; (2) assess the 30-day mortality following morphine, oxycodone, and mixed poisonings compared to tramadol poisonings; and (3) assess the development in tramadol poisonings during a 12-year period. Poisonings were identified from 2006 to 2017. A Cox proportional hazards regression model was used to estimate adjusted hazard ratios (aHRs) along with 95% confidence intervals (CIs) for 30-day mortality following morphine, oxycodone or mixed poisonings compared to tramadol poisonings. We identified 7718 opioid poisonings among 6365 patients. The patients with a tramadol poisoning were younger and had less comorbidities than the patients with a morphine, oxycodone or mixed poisoning. Within 30 days, a total of 205 patients died. The 30-day mortality risk was higher following morphine (aHR 3.2, 95% CI 2.0-5.1), oxycodone (aHR 2.1, 95% CI 1.2-3.6) and mixed poisonings (aHR 1.6, 95% CI 1.0-2.7) compared to tramadol poisonings. The annual number of tramadol poisonings increased from 233 in 2006 to 501 in 2013 and declined to 348 in 2017. In conclusion, despite a lower mortality risk compared to other opioid poisonings, physicians should consider the poisoning and abuse risks when prescribing tramadol.

Keywords: epidemiology; intoxications; mortality; opioids; poisonings.

PubMed Disclaimer

Conflict of interest statement

Espen Jimenez Solem reports grants from Vertex Pharmaceuticals, Eli Lilly, and Novartis outside the submitted work. The other authors report no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Description of the study cohort (1 January 2006 to 31 December 2017)
FIGURE 2
FIGURE 2
Thirty‐day mortality risk for tramadol, morphine, oxycodone, and mixed poisonings

Similar articles

Cited by

References

    1. Babalonis S, Lofwall MR, Nuzzo PA, Siegel AJ, Walsh SL. Abuse liability and reinforcing efficacy of oral tramadol in humans. Drug Alcohol Depend. 2013;129(1–2):116‐124. doi:10.1016/j.drugalcdep.2012.09.018 - DOI - PMC - PubMed
    1. Christrup L, Sædder EA. Potential pharmacological consequences of the development of the opioid consumption in Denmark. Ugeskr Laeger. 2017;179(26):V01170077. - PubMed
    1. Lee CR, McTavish D, Tramadol SEM. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs. 1993;46(2):313‐340. doi:10.2165/00003495-199346020-00008 - DOI - PubMed
    1. Radbruch L, Glaeske G, Grond S, et al. Topical review on the abuse and misuse potential of tramadol and tilidine in Germany. Subst Abus. 2013;34(3):313‐320. doi:10.1080/08897077.2012.735216 - DOI - PubMed
    1. Sørensen AMS, Rasmussen L, Ernst MT, et al. Use of tramadol and other analgesics following media attention and risk minimization actions from regulators: a Danish nationwide drug utilization study. Eur J Clin Pharmacol Published online October. 2020;28. doi:10.1007/s00228-020-03016-6 - DOI - PMC - PubMed